Welcome to the forefront of conversational AI as we explore the fascinating world of AI chatbots in our dedicated blog series. Discover the latest advancements, applications, and strategies that propel the evolution of chatbot technology. From enhancing customer interactions to streamlining business processes, these articles delve into the innovative ways artificial intelligence is shaping the landscape of automated conversational agents. Whether you’re a business owner, developer, or simply intrigued by the future of interactive technology, join us on this journey to unravel the transformative power and endless possibilities of AI chatbots.
Let Healthcare Dive’s free newsletter keep you informed, straight from your inbox.
Users can connect data from their medical records and wellness apps so the popular chatbot can walk them through test results, prepare for appointments with doctors or compare insurance options.
Users are already turning to ChatGPT for health information. More than 40 million people ask the chatbot healthcare questions each day, including queries on navigating the healthcare system and understanding their insurance, according to a report released this week by OpenAI.
And a majority of health conversations take place outside normal clinic hours, suggesting people are taking questions to ChatGPT when they can’t easily access their doctors, the AI firm said.
Releasing a health-specific offering that can utilize users’ personal information should help customers manage their health — often a challenge for patients navigating the complex and fragmented U.S. healthcare system, Fidji Simo, CEO of applications at OpenAI, wrote in a Wednesday blog post.
Many Americans report skipping needed care due to cost concerns, and people living in rural areas often face long travel times to reach providers.
Plus, clinicians often have limited time with patients. Providers have long complained about a growing burden of administrative work and tasks in electronic health records that they say distract from patient care and drag work into off-hours.
“Under these conditions, it’s almost impossible for doctors to look beyond the immediate problem in front of them and see the full picture of someone’s health,” Simo wrote. “That lack of context often means treating individual symptoms in isolation, rather than addressing the underlying drivers.”
The chatbot will first be available to a small group of early users, and OpenAI will expand access to ChatGPT Health in the coming weeks, the company said.
But there are risks to using AI for healthcare. The tools can hallucinate, offering inaccurate or misleading information that many patients could struggle to recognize.
A spokesperson for OpenAI said it worked with physicians to develop and run health-specific evaluations of ChatGPT Health as well as review the model’s responses. More than 260 doctors worked with OpenAI to create HealthBench, a framework that evaluates the chatbot’s answers for safety, clarity and how well it encourages follow-up care with clinicians when needed.
New GPT models are also more accurate and reliable compared to older models, as they’re more likely to ask follow-up questions, browse the internet for the latest research and direct users to professional evaluation, the OpenAI spokesperson said.
Still, ChatGPT Health should not replace medical care, and it isn’t designed for diagnosis or treatment, OpenAI noted. The goal is to ask everyday questions and help users understand patterns in their health over time, the company said.
Get the free daily newsletter read by industry experts
The agency said it would increase the number of MA plan audits and complete its backlog of reviews by investing in technology and growing its medical coding workforce.
The FDA said it’s sending letters to drugmakers demanding they take down or modify ads that don't comply with federal guidelines, out of concern consumers aren’t seeing a “fair balance” of risks and benefits in drug ads.
Subscribe to Healthcare Dive for top news, trends & analysis
Get the free daily newsletter read by industry experts
The agency said it would increase the number of MA plan audits and complete its backlog of reviews by investing in technology and growing its medical coding workforce.
The FDA said it’s sending letters to drugmakers demanding they take down or modify ads that don't comply with federal guidelines, out of concern consumers aren’t seeing a “fair balance” of risks and benefits in drug ads.
The free newsletter covering the top industry headlines